Showing results (121-130 of 288) with videos related to

Sort By:
Pageof 29
Nature|August 12, 2009
Immortalization eliminates a roadblock during cellular reprogramming into iPS cellsJochen Utikal, Jose M Polo, Matthias Stadtfeld, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 15, 2016
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous MelanomaSiri Tähtinen, Carolin Blattner, Markus Vähä-Koskela, et al.
The Journal of Emergency Medicine|February 17, 2018
Bilateral Phlegmasia Cerulea Dolens After Warfarin Reversal for Acute Rectal Bleeding: A Case ReportBurr Fong, Daniel Novak, Michael Dalley, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2018
T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skinCorinne Bauer, Ashik Ahmed Abdul Pari, Viktor Umansky, et al.
Microbiological Research|December 28, 2014
Detection of major diarrheagenic bacterial pathogens by multiplex PCR panelsÅsa Sjöling, Leila Sadeghipoorjahromi, Daniel Novak, et al.
Stem Cell Research|May 23, 2015
Impact of preconditioning with retinoic acid during early development on morphological and functional characteristics of human induced pluripotent stem cell-derived neuronsSandra Horschitz, Friederike Matthäus, Anja Groß, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2011
Comparison of the diagnostic accuracy of whole-body MRI and whole-body CT in stage III/IV malignant melanomaDaniel Hausmann, Susanne Jochum, Jochen Utikal, et al.
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Blood|December 17, 2005
Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathwayJulia Kzhyshkowska, Srinivas Mamidi, Alexei Gratchev, et al.
Cellular Immunology|December 31, 2020
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot studyChristoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.
Pageof 29